About Qritive
Qritive is a healthcare AI company that develops advanced digital pathology solutions to enhance cancer diagnosis and improve patient outcomes. Their core offering includes AI-powered modules that assist pathologists in the identification, grading, and classification of various cancers, such as colon, prostate, lymph node, and breast, along with biomarker analysis. [19] These modules are designed to be hardware-agnostic, allowing for seamless integration into existing digital pathology workflows and platforms, including Qritive’s own Pantheon™ system. [19]
The Pantheon™ platform serves as an AI-powered pathology workbench, providing a single-window operation that integrates with a remote-accessible patient management system. [19] This platform streamlines the pathology workflow from end-to-end, offering tools for case management, reporting, slide viewing and analysis, telepathology, synoptic reporting, and LIS integration. [2, 3] Qritive’s solutions are CE certified and approved by the Singapore Health Sciences Authority (HSA) for clinical use, demonstrating their commitment to clinical-grade AI. [2, 3] By leveraging deep learning technology, Qritive aims to address challenges in pathology such as slow turnaround times, inconsistent diagnoses, and workflow inefficiencies, ultimately enabling faster, more accurate diagnoses and reducing the time to treatment for patients. [7, 15]
Focus Areas
Business Intelligence
| Technology | cloud-native, deep learning technology, AI operating system (Pantheon digital pathology platform) |
What Physicians Need to Know
For physicians, Qritive's solutions offer the potential for faster, more accurate, and consistent cancer diagnoses, reducing the risk of misdiagnosis and accelerating time to treatment. The AI modules can assist in identifying, grading, and classifying various cancers, including prostate, colon, breast, and gastric, as well as lymph node metastasis and biomarker quantification. The Pantheonu2122 platform provides a seamless single-window operation for slide viewing, case management, and AI-supported diagnosis, enhancing workflow efficiency and enabling remote collaboration. The hardware-agnostic nature of their solutions ensures compatibility with existing digital pathology infrastructure.
Qritive's AI modules are designed to integrate seamlessly with various digital pathology workflows and platforms, including their own Pantheonu2122 system and other image management systems. They have a significant collaboration with Roche, integrating their AI-powered solutions with the Roche navifyu00ae Digital Pathology platform to streamline cancer diagnostics. Additionally, they partner with companies like Corista to integrate their AI modules with image management platforms like DP3. Pantheonu2122 also supports integration with major LIS, EMR, PACS, and other hospital information systems.
What the Web Says
Qritive is a Singapore-based AI solution developer focused on advancing digital pathology for cancer diagnosis. Their flagship product, Pantheon, is an AI-powered image management system that digitizes pathology lab workflows, provides automated AI analysis, and aims to improve diagnostic accuracy and efficiency. The company's solutions are designed to assist pathologists in analyzing microscopy images and patient data, potentially reducing diagnosis time by up to 90% and discordance among pathologists by up to 80%. Qritive has partnered with major healthcare providers to integrate its AI technology into cancer diagnosis workflows.
Overall: PositiveStrengths
- AI-powered solutions enhance the accuracy and efficiency of cancer diagnosis.
- Pantheon platform digitizes entire pathology lab workflows and offers automated AI analysis.
- Can significantly reduce diagnosis time and discordance among pathologists.
- AI modules are trained to identify and grade various malignancies and cancer types.
- Vendor-agnostic platform, allowing flexibility with microscopy devices.
- Supports rich report generation and comprehensive case management.
Limitations
- No specific product reviews found on G2, Glassdoor, or Capterra for 'Qritive' (some search results were for similarly named but different companies).
- Limited public information on employer reviews for Qritive specifically; some results were for 'QRI' or 'Curative, Inc.' which are different entities.
- Adopting new AI technologies can be costly, requiring substantial time and capital for development, integration, data amassment, and upskilling personnel.
- General concerns on Reddit about the current accuracy and privacy of AI tools for medical diagnosis, though not specific to Qritive.
Based on reviews from: CXO Today, SourceForge, Slashdot, Tech Collective, Entrepreneurs First, Corista and Qritive Announce Partnership, Roche advances AI-driven cancer diagnostics by expanding its..., Reddit, Indeed.com
Last updated: 2026-10-10
Videos
News, demos, and interviews about Qritive.
Videos load interactively. If none appear, search YouTube for Qritive →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]
Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]